was successfully added to your cart.

Cart

All Posts By

Stu

Warning – review of three Type 2 drugs

By Latest News

The European Medicines Agency (EMA) has started a review of canagliflozin, dapagliflozin and empagliflozin, which are diabetes medicines known as SGLT2 inhibitors. This was requested by the European Commission following several reports of diabetic ketoacidosis in patients on SGLT2 inhibitor treatment for Type 2 diabetes. EMA will now review all available data on the risk of diabetic ketoacidosis (DKA) with SGLT2 inhibitors and consider whether any changes are needed in the way these medicines are used in the EU.

Click here to read more

Diabetes – Parents Passport For Schools

By Latest News

The InDependent Diabetes Trust [IDDT] is all too aware of the difficulties that children with diabetes and their parents face in everyday life when managing the condition. One area that proves particularly problematic is managing the condition at school. With this in mind, IDDT has produced a new, FREE booklet, the Parents Passport for Schools.

Click here to read more

Too many Children with diabetes not getting the care they need

Too many children and young people with diabetes not getting the care they need

By Latest News

The National Paediatric Audit report by the Royal College of Paediatrics and Child Health, March 2015, has shown that in England and Wales only 16.1% of young people aged 12 years and older are receiving the 7 annual checks that every child with diabetes should have. This is a slight improvement from the last audit but still very worrying.

Click here to read more

First ever mandatory care standards to improve the level of care of children and young people with diabetes

InDependent Diabetes Trust
IDDT